citral has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Fan, Z; Fang, Z; Li, H; Li, X; Liu, Z; Pan, X; Wang, C; Wang, Y; Wu, Y; Yu, S | 1 |
| Kamarudin, MNA; Mohan, G; Sarker, MMR; Sheikh, BY | 1 |
2 other study(ies) available for citral and Colorectal Neoplasms
| Article | Year |
|---|---|
Combination Treatment of Citral Potentiates the Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with Pirarubicin for Colorectal Cancer.
Topics: Acyclic Monoterpenes; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Colorectal Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Synergism; Female; HCT116 Cells; Humans; Hyperthermia, Induced; Kaplan-Meier Estimate; Mice; Mice, Inbred BALB C; Monoterpenes; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |
Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines.
Topics: Acyclic Monoterpenes; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; HCT116 Cells; HT29 Cells; Humans; Membrane Potential, Mitochondrial; Mitochondria; Monoterpenes; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2017 |